Re-randomization tests for unplanned changes in clinical trials

Type: Review

Publication Date: 2017-06-16

Citations: 4

DOI: https://doi.org/10.1177/1740774517710657

Locations

Similar Works

Action Title Year Authors
+ Re‐randomization tests in clinical trials 2019 Michael A. Proschan
Lori E. Dodd
+ Assessing Unexpected Circumstances That Lead to Modifications in Clinical Trial Design, Conduct, or Analysis 2022 Maria M. Brooks
Stephen R. Wisniewski
+ Sample Size Recalculation in Clinical Trials with Two Co-primary Endpoints 2016 Toshimitsu Hamasaki
Koko Asakura
Scott Evans
Toshimitsu Ochiai
+ Regulatory Guidance on Randomization and the Use of Randomization Tests in Clinical Trials: A Systematic Review 2023 Kerstine Carter
Annika Scheffold
Jone Renteria
Vance W. Berger
Yuqun Luo
Jonathan Chipman
Oleksandr Sverdlov
+ PDF Chat Adaptive designs in clinical trials: why use them, and how to run and report them 2018 Philip Pallmann
Alun Bedding
Babak Choodari‐Oskooei
Munyaradzi Dimairo
Laura Flight
Lisa V. Hampson
Jane Holmes
Adrian Mander
Lang’o Odondi
Matthew R. Sydes
+ Comment on “Using Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions” 2024 Stephen Senn
+ PDF Chat Commentary on Randomization: The forgotten component of the randomized clinical trial 2018 Janet Wittes
+ Comment on “Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions” 2024 Rachael V. Phillips
Mark J. van der Laan
+ A Regulatory View of Adaptive Trial Design 2008 Mey Wang
Ya‐Chi Wu
Guei‐Feng Tsai
+ Commentary on “Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions” 2024 Qing Liu
+ PDF Chat An introduction to multiplicity issues in clinical trials: the what, why, when and how 2016 Guowei Li
Monica Taljaard
Edwin R. van den Heuvel
Mitchell Levine
Deborah J. Cook
George A. Wells
P.J. Devereaux
Lehana Thabane
+ PDF Chat Adding a treatment arm to an ongoing clinical trial: a review of methodology and practice 2015 D. Cohen
Susan Todd
Walter M. Gregory
Julia Brown
+ Reflections on “Randomization: The Forgotten Component of the Randomized Clinical Trial” 2018 Simon Day
+ Traditional multiplicity adjustment methods in clinical trials 2013 Alex Dmitrienko
Ralph B. D’Agostino
+ Regulatory Guidance on Randomization and the Use of Randomization Tests in Clinical Trials: A Systematic Review 2023 Kerstine Carter
Annika Scheffold
Jone Renteria
Vance W. Berger
Yuqun Luo
Jonathan Chipman
Oleksandr Sverdlov
+ Rerandomization 2022 Kari Lock Morgan
+ PDF Chat Correcting for multiple-testing in multi-arm trials: is it necessary and is it done? 2014 James Wason
Lynne Stecher
Adrian Mander
+ Sample Size Re-Estimation 2021 Tobias MĂźtze
Tim Friede
+ PDF Chat Randomized Clinical Trial Design for Assessing Noninferiority When Superiority Is Expected 2007 Boris Freidlin
Edward L. Korn
Stephen L. George
Robert J. Gray
+ Inference from blinded data in randomized clinical trials 2013 Kefei Zhou
Jitendra Ganju